Format

Send to

Choose Destination
Nat Rev Drug Discov. 2016 Jan;15(1):1-2. doi: 10.1038/nrd.2015.19. Epub 2015 Nov 20.

Towards a hit for every target.

Author information

1
AstraZeneca, Cambridge Science Park, 310 Milton Road, Cambridge CB4 0FZ, UK.
2
Fraunhofer Institute for Molecular Biology and Applied Ecology Ecology IME ScreeningPort, Schnackenburgallee 114, 22525 Hamburg, Germany.
3
AstraZeneca, 2 Kingdom Street, London W2 6BD, UK.
4
Lead Discovery, Epizyme, 400 Technology Square, Cambridge, Massachusetts 02139, USA.

Abstract

Technological advances coupled with novel collaborative strategies for compound sourcing and management are poised to transform the utility of high-throughput screening.

PMID:
26585534
DOI:
10.1038/nrd.2015.19
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center